Skip to content
Alentis TherapeuticsAlentis Therapeutics
  • We are Alentis
    • About Alentis Therapeutics
    • Team
    • Board of Directors
    • Scientific Advisory Board
    • Investors
  • Our Science
    • Pipeline
    • ADCs – ALE.P02 & ALE.P03
    • Fibrosis – Lixudebart (ALE.F02)
    • Publications
  • News
    • Press Releases
    • Videos
  • Careers
  • Toggle website search
Menu Close

Alentis Therapeutics Names Roberto Iacone CEO

  • Post published:July 29, 2020
Continue ReadingAlentis Therapeutics Names Roberto Iacone CEO

ALENTIS Therapeutics launches

  • Post published:April 30, 2019
Continue ReadingALENTIS Therapeutics launches

End of content

No more pages to load

← Newer Posts

Alentis Therapeutics AG

Hegenheimermattweg 167A
4123 Allschwil
Switzerland

Contact:

info@alentis.ch

Statements:

Expanded Access Policy
Cookie Statement
Privacy Statement

Want to know more?
Check our socials

Linkedin Youtube
Close Menu
  • We are Alentis
    • About Alentis Therapeutics
    • Team
    • Board of Directors
    • Scientific Advisory Board
    • Investors
  • Our Science
    • Pipeline
    • ADCs – ALE.P02 & ALE.P03
    • Fibrosis – Lixudebart (ALE.F02)
  • News
    • Press Releases and News
    • Videos
  • Careers

Contact

You’re more than welcome to contact us. Just fill out the form bellow. And we’ll get back tou you as soon as possible.

[contact-form-7 id=”91″ title=”Contact form”]